IL6 and chorioamnionitis: Martinez-Portilla et al. conducted a study in patients between 26–36 + 6 weeks of gestation with pPROM to evaluate the value of the assessment of Il-6 concentration in maternal blood in predicting histopathological chorioamnionitis.